CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $64,118,000 | -40.8% | 2,040,021 | -11.3% | 2.98% | -31.1% |
| Q4 2019 | $108,353,000 | +1282.4% | 2,300,000 | +89.6% | 4.32% | +806.5% |
| Q3 2019 | $7,838,000 | -49.8% | 1,213,274 | -4.6% | 0.48% | -46.8% |
| Q2 2019 | $15,616,000 | -9.4% | 1,271,685 | -0.0% | 0.90% | -23.0% |
| Q1 2019 | $17,231,000 | +237.9% | 1,271,687 | 0.0% | 1.16% | +181.4% |
| Q4 2018 | $5,099,000 | -40.4% | 1,271,687 | 0.0% | 0.41% | -25.5% |
| Q3 2018 | $8,558,000 | – | 1,271,687 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |